Results 221 to 230 of about 265,457 (270)

Sturge-Weber Syndrome: A Rare Clinical Presentation with Bilateral Port-Wine Stain and Leptomeningeal Angiomatosis.

open access: yesIndian J Dermatol
Gomes LLA   +4 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Diphenylhydantoin Gingival Hyperplasia

Archives of Pediatrics & Adolescent Medicine, 1969
DIPHENYLHYDANTOIN (Dilantin) sodium was synthesized in 1908 by Biltz1and introduced as an antiepileptic agent in 1938 by Merritt and Putnam.2Extensive subsequent use of this drug has confirmed its efficacy in controlling epileptic seizures, particularly major motor (grand mal) convulsions.
H L, Livingston, S, Livingston
openaire   +3 more sources

Nifedipine-Induced Gingival Hyperplasia

Drug Intelligence & Clinical Pharmacy, 1986
Gingival hyperplasia, a condition characterized by increased amounts of gingival connective tissue, has most commonly been observed in patients receiving phenytoin, but has also been noted in patients receiving cyclosporine and, as in this case report, nifedipine.
A A, Shaftic   +3 more
openaire   +2 more sources

Characterisation of juvenile spongiotic gingival hyperplasia as an entity of odontogenic origin.

The Journal of Periodontology, 2019
BACKGROUND Juvenile spongiotic gingival hyperplasia (JSGH) is a distinct clinicopathological entity of the buccal gingiva of young patients which has been related to several factors such as plaque formation, hormonal modifications, and viral infections ...
Irene Lafuente‐Ibáñez de Mendoza   +4 more
semanticscholar   +1 more source

[Gingival hyperplasia].

Medizinische Monatsschrift fur Pharmazeuten, 2010
Gingival hyperplasia is a typical adverse reaction of certain drugs (phenytoin, calcium antagonists and cyclosporine). Also oral contraceptives and presumably hormone replacement therapy may rarely lead to gingival hyperplasia. By differential diagnosis a paraneoplastic syndrome has to be taken into account.
Christiane, De Rop   +2 more
openaire   +1 more source

[Proper oral health can protect from developing gingival hyperplasia induced by calcium channel blockers].

Orvosi Hetilap, 2018
Cardiovascular diseases including hypertension affect 40% of the adult population in Hungary. Calcium channel blockers are frequently prescribed for the treatment of hypertension either in monotherapy or in fixed-combination therapy. Their main effect is
Á. Bán, E. Pintér, J. Kun
semanticscholar   +1 more source

Incidence of diphenylhydantoin gingival hyperplasia

Oral Surgery, Oral Medicine, Oral Pathology, 1972
Abstract The incidence of diphenylhydantoin gingival hyperplasia was studied in 173 hospitalized patients who were mainly middle aged and older. The incidence in this series was found to be 53.2 per cent; it was related to the degree of the patients' oral hygiene, while the age, sex, daily dosage of diphenylhydantoin medication, and duration of ...
A P, Angelopoulos, P W, Goaz
openaire   +2 more sources

Localized juvenile spongiotic gingival hyperplasia

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2008
We report 52 cases of a unique and pathologically distinctive form of inflammatory gingival hyperplasia in young patients. Clinically, the average age of patients in this study was 11.8 years, with a 2.3:1 female predominance. Caucasians comprised 77% of the cases, and nearly all of the lesions were located on the anterior gingiva, with 81% affecting ...
Julia Yu Fong, Chang   +2 more
openaire   +2 more sources

Tacrolimus-Induced Gingival Hyperplasia

JCR: Journal of Clinical Rheumatology, 2023
Eaman, Alhassan, Lamees, Al-Hassan
openaire   +2 more sources

[Gingival hyperplasia caused by nifedipine].

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 1986
Fifty patients receiving nifedipine have been observed for the presence of gingival hyperplasia. Thirty were males and 20 females, the mean age was 57.7 ± 14.5 years. The duration of therapy with Nifedipine at the time of dermatological examination was 18.25 ± 16 months (min. 2, max. 48).
P. L. Bencini   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy